GC Green Cross Receives 286.8 Billion Won Advance Payment for Sale of U.S. Eli Lilly’s ‘Curevo’

조선일보

Lean Right

Factuality

Ownership

GC Green Cross has received $189.52 million (approximately 286.8 billion KRW) out of the $204.02 million (approximately 308.7 billion KRW) upfront payment for the sale of its stake in Curevo, a U.S. affiliate, to the U.S. pharmaceutical company Eli Lilly. The remaining $14.5 million (approximately 21.9 billion KRW) is scheduled to be paid following standard settlement procedures. GC Green Cross [regarding] the relationship between Curevo and Lil…